ASP Global, LLC. dba Anatomy Supply Partners SAFE-T-FILL End Caps for SAFE-T-FILL Blood Gas recall — FDA Z-0564-2026
Due to products manufactured under an inadequate quality system to include unvalidated manufacturing processes.
Browse the newest complete recall records currently stored from FDA enforcement reports and NHTSA vehicle campaigns. “Latest” refers to the newest source-dated record in this database, not the timestamp of our last API check.
The newest recall records with useful source details are listed here.
Due to products manufactured under an inadequate quality system to include unvalidated manufacturing processes.
Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing SafeAir Smoke Evacuation Pencils. Stryker Instruments has expanded the scope of their…
Raw milk Peppercorn cheese is recalled due to E.coli O26:H11
Item #28855 Whatcom Blue is recalled due to E. coli O103:H2
Elevated levels of lead in Cinnamon powder.
Raw milk Farmhouse cheeses are recalled due to E. coli O103:H2 and E. coli O74:H25.
Raw milk Mustard Seed cheese is recalled due to E. coli O103:H2 and E. coli O74:H25.
Item #29608 Farmhouse White is recalled due to E. coli O103:H2.
Raw milk Whatcom Blue cheese is recalled due to E. coli O103:H2.
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Failed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate Capsules.
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.
Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Labeling: Label Error on Declared Strength-The overwrap label may incorrectly identify the product as POTASSIUM CHLORIDE Inj. 10 mEq instead of POTASSIUM CHLORIDE Inj. 20 mEq
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.
Browse recent months with enough recall history for useful comparison.